214 related articles for article (PubMed ID: 31122302)
1. Improving Access to High-Cost Technologies in the Asia Region.
Mundy L; Trowman R; Kearney B
Int J Technol Assess Health Care; 2019 Jan; 35(3):168-175. PubMed ID: 31122302
[TBL] [Abstract][Full Text] [Related]
2. OVERCOMING THE BARRIERS TO ACHIEVING UNIVERSAL HEALTH CARE IN THE ASIAN REGION.
Mundy L; Trowman R; Kearney B
Int J Technol Assess Health Care; 2018 Jan; 34(4):352-359. PubMed ID: 29986782
[TBL] [Abstract][Full Text] [Related]
3. ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIA.
Hampson G; Henshall C; Towse A
Int J Technol Assess Health Care; 2017 Jan; 33(2):315-322. PubMed ID: 28554337
[TBL] [Abstract][Full Text] [Related]
4. Sustainability of healthcare systems in Asia: exploring the roles of horizon scanning and reassessment in the health technology assessment landscape.
Mundy L; Trowman R; Kearney B
Int J Technol Assess Health Care; 2020 Jun; 36(3):262-269. PubMed ID: 32389130
[TBL] [Abstract][Full Text] [Related]
5. STAKEHOLDER INVOLVEMENT IN THE HEALTH TECHNOLOGY ASSESSMENT PROCESS IN LATIN AMERICA.
Pichon-Riviere A; Soto N; Augustovski F; Sampietro-Colom L
Int J Technol Assess Health Care; 2018 Jan; 34(3):248-253. PubMed ID: 29888698
[TBL] [Abstract][Full Text] [Related]
6. Hard choices: Reflections from the tomb of the unknown patient.
McCabe C; Round J
Healthc Manage Forum; 2019 Nov; 32(6):288-292. PubMed ID: 31505957
[TBL] [Abstract][Full Text] [Related]
7. Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.
Pichon-Riviere A; Garcia-Marti S; Oortwijn W; Augustovski F; Sampietro-Colom L
Int J Technol Assess Health Care; 2019 Jan; 35(1):64-68. PubMed ID: 30938278
[TBL] [Abstract][Full Text] [Related]
8. "What's Keeping Me Up at Night?" Reflections on the COVID-19 Pandemic in Asia.
Mundy L; Kearney B
Int J Technol Assess Health Care; 2022 Jun; 38(1):e51. PubMed ID: 35702950
[TBL] [Abstract][Full Text] [Related]
9. The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum.
Trowman R; Migliore A; Ollendorf DA
Int J Technol Assess Health Care; 2023 Dec; 39(1):e75. PubMed ID: 38130164
[TBL] [Abstract][Full Text] [Related]
10. HTA capacity building in Asia: towards one goal.
Mundy L; Maddern G
Int J Technol Assess Health Care; 2023 Aug; 39(1):e56. PubMed ID: 37581298
[TBL] [Abstract][Full Text] [Related]
11. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
12. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
Wallner PE; Konski A
J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
[TBL] [Abstract][Full Text] [Related]
13. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
[TBL] [Abstract][Full Text] [Related]
14. Using health technology assessment to support optimal use of technologies in current practice: the challenge of "disinvestment".
Henshall C; Schuller T; Mardhani-Bayne L
Int J Technol Assess Health Care; 2012 Jul; 28(3):203-10. PubMed ID: 22792877
[TBL] [Abstract][Full Text] [Related]
15. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
16. Health technology assessment. The pharmaceutical industry perspective.
Schubert F
Int J Technol Assess Health Care; 2002; 18(2):184-91. PubMed ID: 12053418
[TBL] [Abstract][Full Text] [Related]
17. IMPROVING THE EFFECTIVENESS AND EFFICIENCY OF EVIDENCE PRODUCTION FOR HEALTH TECHNOLOGY ASSESSMENT.
Facey K; Henshall C; Sampietro-Colom L; Thomas S
Int J Technol Assess Health Care; 2015 Jan; 31(4):201-6. PubMed ID: 26646858
[TBL] [Abstract][Full Text] [Related]
18. RETHINKING STAKEHOLDER ENGAGEMENT AND TECHNOLOGY ACCESS IN HEALTH TECHNOLOGY ASSESSMENT: REACTIONS TO POLICY FORUM DISCUSSIONS.
Sampietro-Colom L; Thomas S
Int J Technol Assess Health Care; 2016 Jan; 32(4):200-202. PubMed ID: 27624278
[TBL] [Abstract][Full Text] [Related]
19. Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium.
Van Wilder P; Pirson M; Dupont A
Eur J Clin Pharmacol; 2019 Jul; 75(7):895-900. PubMed ID: 30877328
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based decision-making 3: Health technology assessment.
O'Reilly D; Campbell K; Vanstone M; Bowen JM; Schwartz L; Assasi N; Goeree R
Methods Mol Biol; 2015; 1281():417-41. PubMed ID: 25694325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
